Related Experiment Video
Updated: Apr 6, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting
Min Xie1, Feng-qi Nie2, Ming Sun3
1Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, 210029, Jiangsu, People's Republic of China. 1115769204@qq.com.
Background:
Long noncoding RNAs (lncRNAs) are emerging as key regulators governing fundamental biological processes, and their disorder expression involves in tumorigenesis. SPRY4-IT1 (SPRY4 intronic transcript 1), a lncRNA derived from an intron within SPRY4 gene, involves in multiple cancers development. However, the expression pattern and biological function of SPRY4-IT1 in gastric cancer is still not well documented. Hence, we carried out the present study to investigate the potential role of SPRY4-IT1 in gastric carcinogenesis.
Methods:
QRT-PCR was performed to detect the expression of SPRY4-IT1 in 61 pairs of gastric cancer samples. Over-expression and RNA interference (RNAi) approaches were used to investigate the biological functions of SPRY4-IT1. The effect of SPRY4-IT1 on proliferation was evaluated by MTT and colony formation assays. Gastric cancer cells transfected with pCDNA-SPRY4-IT1 were injected into nude mice to study the effect of SPRY4-IT1 on tumorigenesis and metastasis in vivo. Protein levels of SPRY4-IT1 targets were determined by western blot or fluorescence immunohistochemistry. ChIP assays were performed to investigate the effect of DNMT1 on SPRY4-IT1 expression. Differences between groups were tested for significance using Student's t test (two-tailed).
Results:
SPRY4-IT1 expression is decreased in gastric cancer tissues and associated with larger tumor size, advanced pathological stage, deeper depth of invasion and lymphatic metastasis. Patients with lower SPRY4-IT1 expression had a relatively poor prognosis. DNA methylation may be a key factor in controlling the SPRY4-IT1 expression. Furthermore, SPRY4-IT1 contributed to gastric cancer cells metastasis might partly via regulating epithelial-mesenchymal transition (EMT) process.
Conclusion:
Low expression of SPRY4-IT1 is involved in progression and metastasis of gastric cancer and may represent a novel biomarker of poor prognosis in patients with gastric cancer.
Insights
Decreased SPRY4-IT1 expression in gastric cancer correlates with advanced disease and poor prognosis. This long noncoding RNA may serve as a novel biomarker for gastric cancer progression and metastasis.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long noncoding RNAs (lncRNAs) regulate biological processes; dysregulation is implicated in cancer.
- SPRY4-IT1 (SPRY4 intronic transcript 1) is a lncRNA involved in various cancers.
- Its role in gastric cancer remains underexplored.
Purpose of the Study:
- Investigate the expression pattern of SPRY4-IT1 in gastric cancer.
- Elucidate the biological function and prognostic significance of SPRY4-IT1 in gastric carcinogenesis.
Main Methods:
- Quantitative reverse transcription-polymerase chain reaction (QRT-PCR) to assess SPRY4-IT1 levels in 61 gastric cancer samples.
- In vitro (MTT, colony formation assays) and in vivo (nude mouse xenografts) experiments to evaluate SPRY4-IT1's role in proliferation, tumorigenesis, and metastasis.
- Western blot, fluorescence immunohistochemistry, and ChIP assays to analyze target protein levels and regulatory mechanisms (e.g., DNMT1).
Main Results:
- SPRY4-IT1 expression was significantly decreased in gastric cancer tissues.
- Lower SPRY4-IT1 levels correlated with larger tumor size, advanced stage, deeper invasion, and lymphatic metastasis.
- Reduced SPRY4-IT1 expression was associated with poor patient prognosis.
- DNA methylation may regulate SPRY4-IT1 expression.
- SPRY4-IT1 influenced gastric cancer cell metastasis, partly through regulating epithelial-mesenchymal transition (EMT).
Conclusions:
- Low SPRY4-IT1 expression is linked to gastric cancer progression and metastasis.
- SPRY4-IT1 may serve as a potential biomarker for predicting poor prognosis in gastric cancer patients.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
MicroRNAs
MicroRNAs
Non-LTR Retrotransposons